Change of Quality of Life after Melasma Treatment / 대한피부과학회지
Korean Journal of Dermatology
; : 579-583, 2012.
Article
in En
| WPRIM
| ID: wpr-81293
Responsible library:
WPRO
ABSTRACT
BACKGROUND: Melasma is an acquired, symmetrical hypermelanosis that occurs on sun-exposed areas of the skin. It has significant emotional and psychological effects on those affected with the condition. Melasma Quality of Life Scale (MELASQOL) is a specific questionnaire to identify the most impaired areas of melasma patient's life. OBJECTIVE: Our purpose of this study is to investigate the changing of MELASQOL after the treatment of melasma. METHODS: A total of 27 volunteers with melasma were enrolled in this 8-week treatment study. The patients were instructed to apply an arbutin-containing cream, once a day for 8 weeks. The assessment of outcomes included the colorimetric value (L*) and MELASQOL score. RESULTS: The arbutin-containing cream group increased more in the colorimetric values (L*) after the 8-week treatment (p<0.01). The MELASQOL score was decreased (p=0.02). No significant adverse reactions were observed. CONCLUSION: The treatment of melasma improves the QOL of melasma patients.
Key words
Full text:
1
Index:
WPRIM
Main subject:
Quality of Life
/
Skin
/
Surveys and Questionnaires
/
Hyperpigmentation
/
Melanosis
Limits:
Humans
Language:
En
Journal:
Korean Journal of Dermatology
Year:
2012
Type:
Article